Outset Medical, Inc. (OM)

Market Cap	47.01M
Revenue (ttm)	113.69M
Net Income (ttm)	-127.98M
Shares Out	53.70M
EPS (ttm)	-2.46
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	696,356
Open	0.960
Previous Close	0.960
Day's Range	0.850 - 0.970
52-Week Range	0.435 - 5.220
Beta	2.01
Analysts	Strong Buy
Price Target	4.00 (+356.93%)
Earnings Date	Feb 19, 2025

About OM

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Sep 15, 2020
• Employees: 480
• Stock Exchange: NASDAQ
• Ticker Symbol: OM
• Website: https://www.outsetmedical.com

Financial Performance

In 2024, Outset Medical's revenue was $113.69 million, a decrease of -12.80% compared to the previous year's $130.38 million. Losses were -$127.98 million, -25.94% less than in 2023.

Analyst Forecast

According to 3 analysts, the average rating for OM stock is "Strong Buy." The 12-month stock price forecast is $4.0, which is an increase of 356.93% from the latest price.

Price Target

$4.0

(356.93% upside)

Analyst Consensus: Strong Buy